From: Molecular detection of urogenital mollicutes in patients with invasive malignant prostate tumor
PCa (n = 50) | BPH (n = 55) | |||
---|---|---|---|---|
Age (years) | ||||
< 60 | 2 | (4%) | 5 | (9%) |
60–69 | 9 | (18%) | 17 | (31%) |
70–79 | 23 | (46%) | 22 | (40%) |
> 79 | 16 | (32%) | 11 | (20%) |
PSA level (ng/ml) | ||||
0–4 | 4 | (8%) | 17 | (31%) |
4.1–10 | 7 | (14%) | 17 | (31%) |
10.1–20 | 8 | (16%) | 14 | (25%) |
> 20 | 31 | (62%) | 7 | (13%) |
Gleason score | ||||
6–7 | 12 | (24%) | – | – |
8–10 | 38 | (76%) | – | – |